Synthomer (SYNT) Competitors

Victrex (LON:VCT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, community ranking, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.

Do analysts rate VCT or SYNT?

Victrex presently has a consensus target price of GBX 1,170, indicating a potential upside of 44.98%. Synthomer has a consensus target price of GBX 225, indicating a potential upside of 89.08%. Given Synthomer's stronger consensus rating and higher probable upside, analysts clearly believe Synthomer is more favorable than Victrex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Victrex	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Synthomer	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Is VCT or SYNT more profitable?

Victrex has a net margin of 10.81% compared to Synthomer's net margin of -4.40%. Victrex's return on equity of 6.67% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Victrex	10.81%	6.67%	6.59%
Synthomer	-4.40%	-7.52%	-0.28%

Does the MarketBeat Community favor VCT or SYNT?

Synthomer received 220 more outperform votes than Victrex when rated by MarketBeat users. Likewise, 68.46% of users gave Synthomer an outperform vote while only 63.61% of users gave Victrex an outperform vote.

Company	Underperform	Outperform
Victrex	Outperform Votes 507 63.61%	Underperform Votes 290 36.39%
Synthomer	Outperform Votes 727 68.46%	Underperform Votes 335 31.54%

Is VCT or SYNT a better dividend stock?

Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 7.4%. Synthomer pays an annual dividend of GBX 25 per share and has a dividend yield of 21.0%. Victrex pays out 170.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Synthomer pays out -50.1% of its earnings in the form of a dividend. Synthomer is clearly the better dividend stock, given its higher yield and lower payout ratio.

Do institutionals and insiders have more ownership in VCT or SYNT?

97.1% of Victrex shares are owned by institutional investors. Comparatively, 43.8% of Synthomer shares are owned by institutional investors. 1.6% of Victrex shares are owned by insiders. Comparatively, 28.0% of Synthomer shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Which has more volatility and risk, VCT or SYNT?

Victrex has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500.

Which has higher valuation & earnings, VCT or SYNT?

Victrex has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Victrex	£285.02M	2.47	£30.80M	£35.20	22.93
Synthomer	£1.87B	0.10	-£82.04M	-£49.90	-2.38

Does the media refer more to VCT or SYNT?

In the previous week, Victrex had 1 more articles in the media than Synthomer. MarketBeat recorded 2 mentions for Victrex and 1 mentions for Synthomer. Victrex's average media sentiment score of 0.93 beat Synthomer's score of -0.08 indicating that Victrex is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Victrex	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Synthomer	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Victrex and Synthomer tied by winning 10 of the 20 factors compared between the two stocks.